Results 151 to 160 of about 72,842 (263)

Beyond Gut Modulation: A Critical Review of the Therapeutic Potential, Safety, and Clinical Prospects of Natural Polysaccharides for IBD

Food Safety and Health, EarlyView.
In this review, we critically summarized the application of natural polysaccharides (NPs) for the treatment of IBD. This approach combines, in a unique way (right), the basic structure–activity relationships of NPs from different origins (left) with their multipronged mode of action, which involves modulation of the gut microbiota and other ...
Felix Danso, A. M. Abd El‐Aty, Kwaku Amoah, Xianghong Ju   +3 more
wiley   +1 more source

Durable Response in Histiocytic Sarcoma After Allogeneic Stem Cell Transplantation: A Case Report. [PDF]

Hematol Rep
Oliva S, Gill J, Boccellato E, Mortara U, Molinaro L, Godio L, Sieni E, Buccoliero AM, Dogliotti I, Busca A, Califaretti E, Benedetto B, Giaccone L.   +12 more
europepmc   +1 more source

Case Report: A successful case of allogeneic stem cell transplantation for pediatric XMEN characterized by neutropenia. [PDF]

Front Immunol
Tian J, Zheng J, Qin M, Mao H, Zhu G.
europepmc   +1 more source

A biomarker risk assessment tool predicts infection-related mortality after allogeneic stem cell transplantation. [PDF]

Blood Adv
Tan JLC, Khong T, Kim YJ, Reynolds J, Barmanray RD, Gardiner B, Morrissey CO, Mithraprabhu S, Spencer A.   +8 more
europepmc   +1 more source

Prognostic Value of NT-proBNP in Patients Treated With Allogeneic Stem Cell Transplantation. [PDF]

JACC Adv
Polomski EAS, von dem Borne PA, Veelken H, Heemelaar JC, Jukema JW, Antoni ML.   +5 more
europepmc   +1 more source

Person-Centred Nursing in Allogeneic Stem Cell Transplantation Using a Conversation Tool: A Qualitative Study. [PDF]

Scand J Caring Sci
Engberg de Carvalho C, O'Sullivan A, Bergkvist K, Lundh Hagelin C, Winterling J, Malmborg Kisch A.   +5 more
europepmc   +1 more source

Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party. [PDF]

J Hematol Oncol
Shumilov E, Ngoya M, Berning P, Devillier R, Forcade E, Schroeder T, Kroschinsky F, Stelljes M, Valkova V, Kinsella F, Chevallier P, Olesen G, Mohty M, de Fontbrune FS, Wagner-Drouet E, Zeiser R, Herling M, Franke GN, López-Corral L, Ayuk F, Lenz G, Wulf G, Sureda A, Laurence A, Dreger P, Bazarbachi A, Schmitz N.   +26 more
europepmc   +1 more source

Blinatumomab exposure prior to allogeneic stem cell transplantation is associated with increased Epstein-Barr virus reactivation. [PDF]

Ann Hematol
Sun HL, Zhao ZF, Yin XY, Lv M, Ma L, Wei FF, Zhao XS, Wang Y, Xu LP, Zhang XH, Huang XJ, Pei XY.   +11 more
europepmc   +1 more source

Symptom distress evolution over the first year after allogeneic stem cell transplantation - a prospective observational sub-study of the SMILe project. [PDF]

Support Care Cancer
Schmid A, Ribaut J, De Geest SM, Valenta S, Zeiser R, Denhaerynck K, Kaier K, Teynor A, Leppla L.   +8 more
europepmc   +1 more source

Globo‐H diagnostic stratification and identification of DUSP14 as a candidate target in colorectal cancer

International Journal of Cancer, EarlyView.
What's New? Colorectal cancer (CRC) is increasingly complicated by drug‐resistant tumors that limit the effectiveness of anticancer therapies. Because resistance mechanisms vary among patients and can evolve over time, personalized treatment strategies are needed.
Keren Zohar, Marco Strecker, Thomas Wartmann, Wenjie Shi, Frederike Stelter, Maximilian Doelling, Mihailo Andric, Or Kakhlon, Christian Täger, Denny Schanze, Michael Linnebacher, Michael Naumann, Daniel E. Stange, Dörthe Jechorek, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source